Loading company
$505.87+0.3%Nov 11 close
Figures through September 30, 2026, from the 10-Q filed October 29, 2026
Past performance
- 1W
- +2.2%
- 1M
- +9.8%
- 3M
- +23.1%
- 6M
- +18.8%
- 1Y
- +7.6%
- 5Y
- +114%
Just reported
From HCA Healthcare's results release of October 27, 2026; its quarterly report has since been filed.
Actual
$19.85B
+3.6% y/y
-1.9% q/q
Guided
—
No guide given
Actual
$7.27
+4.5% y/y
-4.6% q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Built from HCA Healthcare, Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$505.87+0.3%Nov 11 close
Figures through September 30, 2026, from the 10-Q filed October 29, 2026
The themes HCA Healthcare is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.$23.3BA+
EHCEncompass Health Corporation$14BA+
ENSGEnsign Group, Inc.$10.9BA
PACSPACS Group, Inc.$7.9BA
CONConcentra Group Holdings Parent, Inc.$5.5BARose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher CorporationOct 21, 2026CBGraded C, now B
MCKMckesson CorporationNov 4, 2026BAGraded B, now A
CVSCVS Health CorpNov 4, 2026BAGraded B, now A
EWEdwards Lifesciences CorporationNov 4, 2026BAGraded B, now A
BIIBBiogen Inc.Oct 28, 2026BAGraded B, now AGrade C
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 31 quarters of HCA Healthcare, Inc.’s grade history. The other 29 go back to February 2019.
